featured image

How Transperineal Biopsies Reduce Infection Risks

featured image

Can a simple change in needle placement dramatically reduce your risk of developing a severe infection after a prostate biopsy? Transperineal prostate biopsies access the prostate through the perineum (the area of skin between the scrotum and rectum) rather than through the rectum. This eliminates bacterial contamination from the bowel and can reduce post-procedure infections compared to transrectal biopsies. The technique involves inserting biopsy needles, the thin, hollow tubes that remove small tissue samples, through sterilised skin, avoiding the rectum entirely. This changes the infection risk profile of prostate cancer diagnosis.

Understanding the Infection Risk in Traditional Biopsies

Transrectal biopsies pass needles through the rectal wall multiple times to reach the prostate. Each needle passage creates a potential pathway for bacteria from the bowel to enter the prostate, bloodstream, and urinary system. The rectum naturally contains a large amount of bacteria. This includes:

  • E. coli, a common bacterium found in the intestines
  • Other organisms that can cause infections when introduced to normally sterile areas of the body

Even with preventive antibiotics given before the procedure, transrectal biopsies carry infection risks. Some bacteria have developed antibiotic resistance, or the ability to survive despite antibiotic treatment. Bacteria that can’t be killed by a typical class of antibiotics, or fluoroquinolone-resistant organisms, pose challenges. These are particularly common in patients with:

  • Recent antibiotic exposure
  • International travel

These resistant bacteria can cause infections ranging from uncomplicated urinary tract infections (infections in the bladder or urinary system causing burning and frequent urination) to sepsis, a severe whole-body infection response that may require hospitalisation.

The infection window after transrectal biopsy extends up to two weeks post-procedure. During this time, bacteria that entered during the biopsy can multiply and spread. They sometimes overwhelm the body’s natural defences even in healthy individuals.

The Transperineal Approach: Anatomical Advantages

The perineum offers a sterile entry point. It can be thoroughly cleaned with surgical antiseptic solutions (disinfectants applied to the skin before surgery to kill bacteria). Unlike the rectum, which cannot be sterilised due to its bacterial ecosystem, perineal skin responds to standard surgical preparation protocols. This creates a clean operative field (the area where the procedure takes place), similar to that in other minor surgical procedures.

The needle path in transperineal biopsy travels through skin, subcutaneous tissue (the layer of fat and tissue beneath the skin), and pelvic floor muscles before reaching the prostate. These tissues have minimal bacterial presence when properly prepared. Any organisms encountered are typically skin flora (harmless bacteria that naturally live on the skin) that rarely cause significant infections. The needles never contact the bowel or its contents.

Transperineal access also supports visualisation and sampling of the anterior prostate (the front portion of the prostate gland). This area may be missed in transrectal biopsies. This coverage means fewer repeat biopsies, thereby reducing cumulative exposure to infection. The technique allows systematic sampling of all prostate zones through a single, sterile entry point.

Clinical Evidence: Infection Rates Compared

Multiple studies demonstrate infection reduction with transperineal techniques. This method involves inserting the biopsy needle through the skin between the scrotum and anus rather than through the rectal wall. Hospital admission rates for post-biopsy sepsis are lower with transperineal methods compared to transrectal approaches. Symptomatic urinary tract infections requiring antibiotic treatment also occur less frequently.

The difference becomes more pronounced in high-risk populations. Men with diabetes, immunosuppression, or recent antibiotic use show improved outcomes with transperineal biopsy. These patients face elevated infection rates with transrectal biopsy. They can experience infection rates similar to the general population when healthcare professionals use the transperineal route.

Emergency department visits within 30 days of biopsy also occur less frequently. Transrectal biopsy patients visit emergency departments primarily for fever, sepsis symptoms, or urinary retention related to infection. Transperineal patients require emergency care less often. When they do, it’s typically for minor issues, such as temporary urinary difficulties unrelated to infection.

Antibiotic Protocols

Transperineal biopsies often require only a single dose of prophylactic antibiotics at the time of the procedure. This contrasts with transrectal biopsies, which typically require multiple days of oral antibiotics before and after the procedure. Some centres perform transperineal biopsies without any antibiotics in selected patients.

Reduced antibiotic use offers several advantages:

  • Patients avoid antibiotic side effects, including gastrointestinal upset, allergic reactions, and disruption of normal bacterial flora
  • The risk of developing antibiotic-resistant organisms decreases
  • Healthcare systems benefit from reduced antibiotic consumption and lower rates of resistant infections

For patients with antibiotic allergies or previous adverse reactions, a transperineal biopsy can provide a suitable option. The minimal antibiotic requirement means alternative agents can be used if needed. In some cases, antibiotics can be avoided entirely under appropriate protocols.

The Procedure: Step-by-Step Safety Measures

Patient positioning begins with the lithotomy position (where you lie on your back with your legs raised and supported), similar to that used for cystoscopy. The perineum, or the area between the scrotum and anus, is shaved if necessary. It is cleaned with chlorhexidine or iodine-based solutions in expanding circles, creating a sterile field extending well beyond the biopsy site. Sterile drapes isolate the prepared area from potential sources of contamination.

Your healthcare provider injects local anaesthetic around the prostate through the perineum, providing pain control without the infection risks of rectal nerve blocks. The anaesthetic also hydro-dissects tissue planes (separates tissue layers using fluid pressure), creating additional separation between the needle path and any potential contamination.

A biopsy grid or freehand technique guides needle placement through the perineum. Each needle passes through the same sterilised entry point or nearby areas within the sterile field. The ultrasound probe, placed in the rectum but covered with a sterile sheath, never contacts the biopsy needles. Fusion systems can overlay MRI images onto real-time ultrasound, supporting targeting accuracy while maintaining sterility.

Recovery and Monitoring

Post-procedure recovery focuses on comfort rather than infection surveillance. Patients typically experience mild perineal discomfort (soreness between the scrotum and anus) that lasts a day or two. Simple pain relievers can help manage this discomfort. Applying ice packs to the perineum for brief intervals can reduce swelling and discomfort.

Blood in urine appears in some patients but clears within days to a week. This represents mechanical trauma (physical tissue disruption from the needle) rather than infection. It requires no specific treatment beyond maintaining good hydration. Blood in semen may persist for several weeks but poses no health risk.

Temperature monitoring, necessary after a transrectal biopsy (a biopsy taken through the rectal wall), becomes less urgent with transperineal approaches. Patients should still report fever, but the likelihood of infection-related fever is minimal. Post-procedure fevers, when they occur, are often due to dehydration or unrelated viral illnesses rather than biopsy-related infections.

💡 Did You Know?
The transperineal biopsy technique was actually the original method for prostate sampling, used before ultrasound guidance made transrectal access popular. Modern technology has brought this approach back to prostate diagnostics.

Special Populations: Potential Benefits

Immunocompromised patients. Or the people whose immune systems are weakened, such as those receiving chemotherapy for cancer, medications for autoimmune conditions, or drugs to prevent organ transplant rejection, face infection risks with transrectal biopsy. This procedure involves a needle passing through the rectal wall. Transperineal access offers an alternative. The needle enters through the skin between the scrotum and anus instead. This approach allows these patients to undergo the necessary prostate evaluation with reduced infection risks.

Men with inflammatory bowel disease (chronic conditions causing intestinal inflammation, such as Crohn’s disease or ulcerative colitis) may benefit from avoiding transrectal needle passage. This is particularly true for those with active disease or recent flares. The transperineal route eliminates risks of triggering bowel inflammation. It also prevents the creation of abnormal connections between organs (fistulas) whilst maintaining diagnostic accuracy.

Patients with artificial joints or heart valves traditionally require extended antibiotic prophylaxis for transrectal biopsies. Prophylaxis involves preventive antibiotics given before the procedure. This precaution addresses risks of bacteria entering the bloodstream. Reduced rates of bacteria entering the bloodstream in transperineal biopsies may allow simplified prophylaxis protocols. Your healthcare provider can assess your individual needs.

Managing Expectations

Mild perineal bruising (discolouration of the skin between the scrotum and anus) occurs commonly. It typically resolves within a week. Some men experience temporary difficulty initiating urination due to prostate swelling. This usually resolves within a day or two. Unlike infection-related retention (the inability to empty the bladder), mechanical effects after transrectal biopsy respond well to alpha-blockers (medications that relax muscles in the prostate and bladder neck) or temporary catheterisation (a thin tube inserted to drain urine) when necessary.

Sexual activity can usually resume after a few days, once perineal discomfort resolves and initial bleeding stops. This timeline differs from the more extended abstinence often recommended after transrectal biopsy due to infection concerns.

Return to routine activities, including exercise and work, typically occurs within a few days. The absence of infection risk means patients don’t need to limit activities to watch for sepsis symptoms and signs of severe infection spreading through the body, such as fever, rapid heart rate, or confusion. Travel, often restricted after transrectal biopsy due to infection risk, can proceed as planned following transperineal procedures.

Preparation Steps for Safety

  • Medication Review: Your urologist will provide a specific timeline for stopping blood thinners (medications that prevent blood clots, such as warfarin or clopidogrel). This is typically several days before the procedure.
  • Hygiene Preparation: Shower with antibacterial soap the morning of the procedure. Pay attention to the genital and perineal area.
  • Bowel Preparation: Empty your bowels naturally before the procedure if possible. Formal preparation is unnecessary.
  • Clothing Choice: Wear loose-fitting underwear and trousers to help minimise post-procedure discomfort.
  • Transportation Planning: Arrange for someone to drive you home if sedation will be used.

When to Seek Professional Help

  • Fever above 38°C (100.4°F) persisting more than 24 hours
  • Inability to urinate for more than 8 hours despite trying
  • Heavy bleeding requiring more than one pad per hour
  • Severe pain uncontrolled by prescribed medications
  • Swelling or redness at the biopsy site (where the tissue sample was taken) that worsens after 48 hours
  • Persistent nausea or vomiting preventing fluid intake
  • Confusion or significant weakness developing after the procedure
  • Blood clots in urine are larger than small pebbles

Commonly Asked Questions

How long does the reduced infection protection last after transperineal biopsy?

The infection risk remains low throughout the entire recovery period. Since bacteria do not enter the prostate during the procedure, there is no delayed infection risk like that seen with transrectal biopsies. With transrectal biopsies, bacteria from the rectum can potentially cause infections days after the procedure. Complications, if any occur, typically manifest within the first couple of days and are usually minor.

Can transperineal biopsy detect the same cancers as transrectal biopsy?

Transperineal biopsy provides access to all prostate zones. It particularly accesses the anterior region (the front part of the prostate) where cancers can be located. The detection rate is comparable to that of transrectal biopsy. It offers tumour mapping for treatment planning.

Why isn’t transperineal biopsy offered everywhere?

The technique requires specialised training and equipment setup, unlike transrectal biopsy. Many centres are transitioning to transperineal approaches as equipment becomes more available and healthcare professionals complete training. The initial investment in equipment and training is offset by reduced complication rates and hospital admissions.

Does the lower infection risk mean I can skip follow-up appointments?

Follow-up remains vital to discuss biopsy results and plan any necessary treatment. However, urgent post-procedure visits for infection symptoms become rare. This makes the recovery process more predictable and convenient.

Next Steps

Transperineal biopsy provides superior infection safety compared to traditional transrectal approaches. The technique requires minimal antibiotic use and reduces hospital readmissions. Consider discussing this option with your urologist if you need a prostate biopsy.

If you are experiencing urinary symptoms, need a prostate biopsy, or have concerns about infection risks from previous biopsy experiences, schedule a consultation with a urologist to evaluate whether a transperineal biopsy is appropriate for your situation.